Taken together, we therefore propose that ZMIZ1 functions as part of the estrogen response by being in close proximity to, or in, the ER complex, thus enabling the efficient expression of cycle cell-related genes in response to estrogen due to a convergence of ER and ZMIZ1 activity at the E2F2 promoter in breast cancer. The gene discussed is ESR1; the disease is breast cancer.